| COX2 |
P00403
|
cytochrome c oxidase subunit II
|
Enzyme
|
|
0.352 |
0.962 |
| MIR21 |
|
microRNA 21
|
|
|
0.363 |
0.846 |
| MTCO2P12 |
|
MT-CO2 pseudogene 12
|
|
|
0.368 |
0.962 |
| IFNA1 |
P01562
|
interferon alpha 1
|
|
|
0.371 |
0.923 |
| IFNA13 |
P01562
|
interferon alpha 13
|
|
|
0.374 |
0.923 |
| COX1 |
P00395
|
cytochrome c oxidase subunit I
|
Enzyme
|
|
0.441 |
0.885 |
| IFNA2 |
P01563
|
interferon alpha 2
|
|
|
0.442 |
0.885 |
| COPD |
|
Pulmonary disease, chronic obstructive, severe early-onset
|
|
|
0.456 |
0.885 |
| CBLL2 |
Q8N7E2
|
Cbl proto-oncogene like 2
|
Enzyme
|
|
0.476 |
0.808 |
| RN7SL263P |
|
RNA, 7SL, cytoplasmic 263, pseudogene
|
|
|
0.496 |
0.808 |
| GGTLC5P |
|
gamma-glutamyltransferase light chain 5 pseudogene
|
|
|
0.513 |
0.846 |
| GGTLC3 |
B5MD39
|
gamma-glutamyltransferase light chain family member 3
|
|
|
0.513 |
0.846 |
| GGTLC4P |
|
gamma-glutamyltransferase light chain 4 pseudogene
|
|
|
0.513 |
0.846 |
| MIR499A |
|
microRNA 499a
|
|
|
0.519 |
0.846 |
| TAM |
|
Myeloproliferative syndrome, transient (transient abnormal
|
|
|
0.528 |
0.731 |
| IGAN1 |
|
IgA nephropathy
|
|
|
0.524 |
0.808 |
| UGT1A |
|
UDP glucuronosyltransferase family 1 member A complex locus
|
|
|
0.540 |
0.654 |
| ATHS |
|
atherosclerosis susceptibility (lipoprotein associated)
|
|
|
0.551 |
0.769 |
| MIR216A |
|
microRNA 216a
|
|
|
0.582 |
0.654 |
| DIANPH |
|
diabetic nephropathy
|
|
|
0.678 |
0.500 |
| KIR2DS4 |
P43632
|
killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 4
|
Receptor
|
|
0.674 |
0.500 |
| MIR499B |
|
microRNA 499b
|
|
|
0.760 |
0.269 |
| LPA |
P08519
|
lipoprotein(a)
|
Enzyme
|
6.6E-89 |
0.444 |
0.769 |
| PKHD1 |
P08F94
|
PKHD1 ciliary IPT domain containing fibrocystin/polyductin
|
|
1.2E-47 |
0.576 |
0.654 |
| CUBN |
O60494
|
cubilin
|
|
4.6E-42 |
0.587 |
0.769 |